ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021
13 janv. 2021 05h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his...
Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives
18 déc. 2020 10h14 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
GelSana Receives Pre-Seed Investment from Innosphere Ventures
30 nov. 2020 12h22 HE
|
Innosphere Ventures
Golden and Fort Collins, CO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Innosphere Ventures, Colorado’s commercialization program and seed-stage venture capital fund, has announced their investment in...
APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an “Off-the-Shelf” Allogeneic Stem Cell Product for the Treatment of Diabetic Ulcers
28 oct. 2020 20h08 HE
|
APstem Therapeutics
Fremont, CA , Oct. 28, 2020 (GLOBE NEWSWIRE) -- APstem Therapeutics, Inc., a private biopharmaceutical company developing breakthrough stem cell therapies, today announced the completion of an...
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkin
05 déc. 2019 09h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
SANUWAVE Announces DFU Joint Investigational Partnership with HyperMed
11 juil. 2018 13h20 HE
|
SANUWAVE Health, Inc.
SUWANEE, GA, July 11, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a partnership with HyperMed in Memphis, TN to sponsor a continuing clinical investigation on...
Antiulcerant Drugs to Escalate in Emerging Markets to 2022
06 juin 2018 14h00 HE
|
BCC Research
WELLESLEY, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Rising disposable income in developed countries, growing awareness of ulcer disease and advances such as big data, 3D printing and IoT are aiding...
SANUWAVE Announces First Shipments of the dermaPACE System in the U.S. Market
02 mars 2018 09h00 HE
|
SANUWAVE Health, Inc.
SUWANEE, GA, March 02, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the first product shipments in the U.S. market of the company’s dermaPACE®System...
SANUWAVE Announces Exhibition at Wounds Canada 2018 Spring Conference
07 févr. 2018 08h30 HE
|
SANUWAVE Health, Inc.
SUWANEE, GA, Feb. 07, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at Wounds Canada 2018 Spring Conference in Winnipeg, Manitoba...